OBN Awards
OBN Awards 2024 20 November 2024 London, United Kingdom More information
European Lifestars Awards
European Lifestars Awards 18 November 2024 London, United Kingdom More information
Investival Showcase
Investival Showcase 18 November 2024 London, United Kingdom More information
Bio-Europe 2024
Bio-Europe 2024 4-6 November 2024 Stockholm, Sweden More information
Tessellate BIO Announces Appointment of Lara Boyd as Chief Business Officer
Amsterdam, the Netherlands and Stevenage, UK – 4 November 2024 – Tessellate BIO, a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches, today announces the appointment of Dr. Lara Boyd as Chief Business Officer. Lara joins Tessellate BIO from F-star Therapeutics, an innovation focused biotech company dedicated to delivering next-generation multispecific […]
Tessellate BIO, Omico and CMRI announce a multi-year collaboration to accelerate discovery of synthetic lethal precision therapies to address ‘ALT’ cancers
Amsterdam, the Netherlands and Sydney, Australia 30 September 2024 – Tessellate BIO, a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches, announces a collaboration with CMRI, a leading Australian pediatric medical research institute, and Omico, an organization uniting over 50 world-class cancer institutes in Australia and New Zealand. The collaboration has […]
Tessellate BIO Announces Appointment of Professor Sandra Strauss to Scientific Advisory Board
Amsterdam, the Netherlands and London, UK – 1 May 2024 – Tessellate BIO, a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches, today announces the appointment of Professor Sandra Strauss, University College London, to its Scientific Advisory Board. The SAB, which recently convened a successful meeting in San Diego ahead of the […]
© Tessellate Bio
